|
Volumn 25, Issue 6, 1997, Pages 1351-1360
|
Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study
a,b a,c d d e b f g e h h a,i j j |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMMONIA;
FRUCTOSE;
MACROGOL;
ORNITHINE ASPARTATE;
PLACEBO;
PROTEIN;
RIBOFLAVIN;
ADULT;
AGED;
AMMONIA BLOOD LEVEL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIGESTIVE SYSTEM FUNCTION DISORDER;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
GOOD CLINICAL PRACTICE;
GOOD LABORATORY PRACTICE;
HEPATIC ENCEPHALOPATHY;
HUMAN;
HYPERAMMONEMIA;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER CIRRHOSIS;
MAJOR CLINICAL STUDY;
MALE;
MENTAL HEALTH;
MULTICENTER STUDY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROTEIN INTAKE;
PSYCHOMETRY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ADULT;
AGED;
AMMONIA;
DIPEPTIDES;
DOUBLE-BLIND METHOD;
FEMALE;
HEPATIC ENCEPHALOPATHY;
HUMANS;
INFUSIONS, INTRAVENOUS;
LIVER CIRRHOSIS;
MALE;
MENTAL HEALTH;
MIDDLE AGED;
PLACEBOS;
VEINS;
|
EID: 0031003989
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.510250609 Document Type: Review |
Times cited : (294)
|
References (13)
|